Potential New Target in Chronic Spontaneous Urticaria
Summary
MRGPRX2 inhibitors could expand options beyond current therapies
Description
MRGPRX2 inhibitors could expand options beyond current therapies
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source